InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Barrage Khalil, Director. Director active across 1 companies, notably Protagenic Therapeutics, Inc.\new. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€46,63745,000 shares@ €1.0364100.0% of flow
Protagenic Therapeutics, Inc. Common Stock
SEC:0001493152-21-010465·
€46,63745,000 shares@ €1.03643.96% mcap50.0% of flow
Protagenic Therapeutics, Inc. Common Stock
SEC:0001493152-21-010465:0·
2 of 2 declarations
About Barrage Khalil
Khalil Barrage is a Board Member at Protagenic Therapeutics, Inc. He contributes to the governance of the company, bringing his expertise in strategy and leadership. His role is essential for guiding strategic decisions and ensuring compliance with industry standards.
